Discovery of potential covalent TYK2 inhibitors targeting Cys736 for the treatment of psoriasis
{{output}}
TYK2 regulates the signaling of pro-inflammatory cytokines such as IL-12, IL-23, and type I interferons, which directly modulates immune cell activation and inflammatory responses, thereby has emerged as a promising therapeutic target for psoriasis. In this st... ...
